Top of page
Health

Cystic fibrosis Orkambi drug will ‘transform lives’ of young people

Colorful pills and capsules

The lives of young people with cystic fibrosis will be “transformed” by a life-extending drug approved to treat the condition, campaigners have said.

Earlier this month , the Department of Health confirmed its intention to make Orkambi available in Northern Ireland. It improves lung function in those with cystic fibrosis – a life-shortening genetic condition that can cause fatal lung damage.

Approximately one in 2,500 babies born in the UK has cystic fibrosis. Only about half of those with the condition live to the age of 32.

Orkambi does not work for all patients, but two other drugs to treat cystic fibrosis symptoms, Symkevi and Kalydeco, will also be made available in Northern Ireland.

Symkevi is restricted to over 12-year-olds, while Kalydeco can be used from 12 months. Families have campaigned for Orkambi since 2015, when it was licensed to treat certain cystic fibrosis patients.

The drug can be given to children as young as two.The drug, which costs approximately £104,000 a year per patient, was deemed too expensive by the health advisory body, NICE.

Cystic fibrosis is an inherited condition in which the lungs and digestive system can become clogged with thick, sticky mucus. It can cause problems with breathing and digestion from a young age.

You might also like

kid boy Upset, sitting in the dark kid boy Upset, sitting in the dark

Childhood maltreatment accounts to 40% of mental health conditions

The mental health conditions examined were anxiety, depression, harmful alcohol…

Doctor holding a digital tablet with x-ray of brain and skull skeleton Doctor holding a digital tablet with x-ray of brain and skull skeleton

WHO and France host high-level meeting to tackle meningitis

Global leaders highlight the need to defeat meningitis – a leading…

a teenage with autism relaxing with rocking chair a teenage with autism relaxing with rocking chair

Specialist autism diagnostic service launches for at-risk young people

A first-of-its-kind service is underway from this month to provide…

Shelby Rowe, second from right, executive director of the Suicide Prevention Resource Center at the University of Oklahoma, speaks at a White House panel discussion Tuesday with actress Ashley Judd, second from left, and singer-songwriter Aloe Blacc, right. The discussion, facilitated by U.S. Surgeon General Vivek Murthy, M.D., MBA, left, was held to mark the release of the National Strategy for Suicide Prevention. Shelby Rowe, second from right, executive director of the Suicide Prevention Resource Center at the University of Oklahoma, speaks at a White House panel discussion Tuesday with actress Ashley Judd, second from left, and singer-songwriter Aloe Blacc, right. The discussion, facilitated by U.S. Surgeon General Vivek Murthy, M.D., MBA, left, was held to mark the release of the National Strategy for Suicide Prevention.

University of Oklahoma assists in New National Suicide Prevention Plan

The Biden-Harris Administration, through the U.S. Department of Health and…